Discover the detailed record of transactions filed by Ildstad Suzanne, Directrice Scientifique. Officer active across 1 company, notably Talaris Therapeutics, Inc.. Aggregated, 2 filings have been recorded. Activity tracked since 17 November 2021. The latest transaction was disclosed on 17 November 2021 (Don). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Suzanne Ildstad is the Chief Scientific Officer at Talaris Therapeutics, Inc. She is responsible for leading the company's research and development initiatives, ensuring innovation and advancement in therapeutic technologies. Suzanne Ildstad plays a key role in the scientific direction of the company, contributing to its success in the biotechnology field.